QIPP & Emollient Prescribing

Zeroderma Range of Emollients

Zeroderma emollients offer similar products to leading brands with no compromise on patient care and cost savings of up to 37%.

More about the Zeroderma range | Zeroderma Prescribing Information | More about T&R Derma

The Zeroderma range of emollients

"The emollient of choice is the least expensive one that is effective, which the patient finds acceptable and is prepared to use on a regular basis" MeReC 1998

The Zeroderma range of emollients consists of 4 creams, an ointment, a gel and 2 bath additives.

The following price comparison table is available as a PDF to download complete with datasheets comparing each product in the Zeroderma range to the similar leading brands.

The transparent pricing policy of the Zeroderma range avoids the administrative burden of complex rebate schemes.

Zeroderma Range Similar Brand Saving per pack Info
Cream
Zerobase Cream Zerobase £5.26 500g
£1.04 50g
Diprobase £6.32 500g
£1.28 50g
17%
19%

Zerobase/Diprobase comparison PDF

Zerobase moisturising
effect PDF

Zerocream Zerocream £4.08 500g
£1.17 50g
E45 £5.62 500g
£1.61 50g
27%
27%

Zerocream/E45 comparison PDF

ZeroAQS ZeroAQS £3.29 500g
Aqueous Cream £4.40 500g
25%

ZeroAQS/Aqueous Cream comparison PDF

Rich Cream
Zeroguent Zeroguent £6.99 500g
£2.33 100g
Unguentum M £8.48 500g
£2.78 100g
18%
16%

Zeroguent/Unguentum M comparison PDF

Gel
Zerodouble Zerodouble £4.71 475g
£2.25 100g
Doublebase £5.83 500g
£2.65 100g
19%
15%

Zerodouble/Doublebase comparison PDF

Ointment
Zeroderm Zeroderm £4.10 500g
£2.41 125g
Epaderm £6.53 500g
£3.85 125g
37%
37%

Zeroderm/Epaderm /Hydromol comparison PDF

Hydromol £4.89 500g
£2.88 125g
16%
16%
Bath Additives
Zerolatum Zerolatum £4.79 500ml Oilatum Junior £5.89 600ml 19%

Zerolatum/Oilatum Junior comparison PDF

Zeroneum Zeroneum £4.48 500ml Balneum £5.38 500ml 17%

Zeroneum/Balneum comparison PDF

Source: Chemist+Druggist August 2016 except aqueous cream: Drug Tariff August 2016

QIPP & Emollients

Guidance for emollient prescribing

  • "Emollients should form the basis of atopic eczema management and should always be used, even when the atopic eczema is clear" NICE CG57
  • "The emollient of choice is the least expensive one that is effective, which the patient finds acceptable and is prepared to use on a regular basis" MeReC 1998
  • "There is a lack of good quality evidence comparing emollients" MeReC 1998

Patient acceptability & retention

  • "Cosmetic acceptability of emollient products is one of the most important factors which determine its acceptability" Cork and Danby 2009
  • In areas where the Zeroderma range has been introduced to replace leading emollient brands, the products have been accepted very well:
    • "The switch was very well received by GPs and patients"
    • "I haven't heard of any patients being switched back"
    • "Patients and GPs are positive about the switch as it had no negative impact on care"
      NHS Sheffield

Cost-effectiveness

  • There is a current trend to restrict emollient prescribing to save money. "Emollients ... should always be used even when atopic eczema is clear" NICE
  • NHS Sheffield are on track to save £250,000 on emollients over the next 3 years without compromising on patient care:
    • "It is not sufficient to just add products to the formulary, change needs to be steered through to ensure prescribing practices are altered at practice level to achieve cost efficiencies"
      NHS Sheffield
  • Visit the Savings for Your Area tab to see how much you could save

Savings are easy to implement

  • A formulary template and suite of practice support tools are available (see tabs above). They have been developed from tried and tested medicines management materials which have been used to deliver cost and quality improvements in emollient prescribing.

Emollient Prescribing Trends in England

In the 5 years to December 2013, the use of proprietary emollients has almost doubled whereas demand for non-proprietary emollients continues to decline, mainly due to the decrease in demand for Aqueous cream. In 2013 the MHRA released a Drug Safety Update stating that Aqueous cream "May cause skin irritation, particularly in children with eczema, possibly due to sodium lauryl sulphate content".

The full report of the NHS National Skin Preparations Charts can be downloaded from NHS Business Services Authority.

 

Proprietary emollients, creams & ointments

Non-proprietary emollients, creams & ointments

Emollient bath & shower additives

 

© Copyright NHSBSA 2014

Savings for NHS England, Wales, Scotland & N. Ireland

The annual total emollient spend for NHS England, Wales, Scotland & N. Ireland during the 12 months ending Dec 2014 was £145m (NHS PCA data, December 2014). Of this 39% could be substituted with the Zeroderma range of emollients.

The NHS could save over £12m with the Zeroderma range.

Savings for your area

Please login or complete the form below to view detailed analysis of savings for your area:

Log in:

 

Need a username and password?

Registration is FREE, quick and open to NHS employees. Please complete the following and we'll email login details to you:

Occasionally we will email you with details of new product launches and cost-saving updates. Please tick here if you prefer not to receive them. We NEVER share your details with other companies.

Please check here to confirm you will keep your login information confidential

Formulary template

A Formulary template has been produced from a document prepared by NHS Surrey for you to review and adapt locally.

Please login or complete the form below to access the template.

Log in:

 

Need a username and password?

Registration is FREE, quick and open to NHS employees. Please complete the following and we'll email login details to you:

Occasionally we will email you with details of new product launches and cost-saving updates. Please tick here if you prefer not to receive them. We NEVER share your details with other companies.

Please check here to confirm you will keep your login information confidential

Practice support tools

A suite of documents have been designed to make it easier for GPs, pharmacists and patients to change over to Zeroderma emollients. These are examples of templates for some of the Zeroderma range which can be quickly adapted to reflect local requirements.

Please login or complete the form below to access the practice support tools.

Log in:

 

Need a username and password?

Registration is FREE, quick and open to NHS employees. Please complete the following and we'll email login details to you:

Occasionally we will email you with details of new product launches and cost-saving updates. Please tick here if you prefer not to receive them. We NEVER share your details with other companies.

Please check here to confirm you will keep your login information confidential

Case studies

Many CCGs are already taking advantage of the huge cost savings that the Zeroderma range of emollients is able to offer without compromising patient care. In this section we highlight three examples:

1) A 2012 case study by Charlotte Hastie, Pharmacist Team Leader - Medicines Management Team NHS Sheffield. NHS Sheffield are projecting savings of £250,000 over 3 years by switching patients to the Zeroderma range.

2) An ongoing QIPP project in NHS Surrey which was started in 2012 and is already yielding annual savings of £44,000 with more work still to do.

3) NHS Waltham Forest CCG is on target to make annualised savings of approximately £45,000 by switching patients to the Zeroderma range. The change has been very well received by both patients and practices.

Please login or complete the form below to view the case studies.

Log in:

 

Need a username and password?

Registration is FREE, quick and open to NHS employees. Please complete the following and we'll email login details to you:

Occasionally we will email you with details of new product launches and cost-saving updates. Please tick here if you prefer not to receive them. We NEVER share your details with other companies.

Please check here to confirm you will keep your login information confidential

container bottom